2025
SJR Q1
JCR Q2 · 4
1 matched articles
SCIE
Journal detail
Current Hematologic Malignancy Reports
- Publisher
- Springer
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
155882111558822X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,191
- Quartile Q1
- H-Index 52
- Cites/doc 4,34
- Docs (3y) 89
- Cites (3y) 339
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4
- 5Y JIF 2,9
- JCI 0,47
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q2
- Hematology Q1
- Oncology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology | Hematology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,191 | 4 | 2,9 | 0,47 | Q3 | 52 |
| 2024 | Q1 | Q2 | 1,123 | 3,3 | 2,9 | 0,44 | Q3 | 48 |
| 2023 | Q1 | Q2 | 0,998 | 2,7 | 3 | 0,41 | Q3 | 48 |
| 2022 | Q2 | Q3 | 0,914 | 2,9 | 3 | 0,44 | Q3 | 48 |
| 2021 | Q1 | Q2 | 1,125 | 4,2 | 3,8 | 0,49 | Q3 | 48 |
| 2020 | Q1 | Q2 | 1,299 | 4 | 3,2 | 0,43 | Q3 | 48 |
| 2019 | Q2 | Q3 | 0,98 | 2,5 | 2,2 | 0,41 | Q3 | 48 |
| 2018 | — | Q3 | — | 2,4 | 2,1 | 0,42 | Q3 | — |
| 2017 | Q2 | Q3 | 1,072 | 2,4 | 2,2 | 0,48 | Q3 | 48 |
| 2016 | Q2 | Q3 | 1,116 | 2 | 1,9 | — | — | 48 |
| 2015 | Q2 | Q3 | 1,033 | 2,1 | 2 | — | — | 48 |
| 2014 | Q2 | Q3 | 1,11 | 2,2 | — | — | — | 48 |
| 2013 | Q1 | Q3 | 1,228 | 2,3 | — | — | — | 48 |
| 2012 | Q2 | Q3 | 0,796 | 1,9 | — | — | — | 48 |
| 2011 | Q2 | — | 0,681 | — | — | — | — | 48 |
| 2010 | Q3 | — | 0,167 | — | — | — | — | 48 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | HEMATOLOGY | SCIE | Q2 | Q3 | 27/103 |
| 2025 | ONCOLOGY | SCIE | Q2 | Q3 | 116/333 |
| 2024 | HEMATOLOGY | SCIE | Q2 | Q3 | 28/99 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q3 | 123/328 |
| 2023 | HEMATOLOGY | SCIE | Q2 | Q3 | 35/97 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q3 | 163/322 |
| 2022 | HEMATOLOGY | SCIE | Q3 | Q3 | 48/79 |
| 2022 | ONCOLOGY | SCIE | Q3 | Q3 | 163/241 |
| 2021 | HEMATOLOGY | SCIE | Q2 | Q3 | 36/78 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q3 | 125/245 |
| 2020 | HEMATOLOGY | SCIE | Q2 | Q3 | 29/76 |
| 2020 | ONCOLOGY | SCIE | Q3 | Q4 | 130/242 |
| 2019 | HEMATOLOGY | SCIE | Q3 | Q3 | 43/76 |
| 2019 | ONCOLOGY | SCIE | Q3 | Q4 | 169/244 |
| 2018 | HEMATOLOGY | SCIE | Q3 | Q3 | 45/73 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q4 | 158/230 |
| 2017 | HEMATOLOGY | SCIE | Q3 | Q3 | 39/71 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q3 | 158/223 |
| 2016 | HEMATOLOGY | SCIE | Q3 | — | 45/70 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 158/217 |
| 2015 | HEMATOLOGY | SCIE | Q3 | — | 48/70 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 146/213 |
| 2014 | HEMATOLOGY | SCIE | Q3 | — | 43/68 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 143/211 |
| 2013 | HEMATOLOGY | SCIE | Q3 | — | 40/68 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 124/203 |
| 2012 | HEMATOLOGY | SCIE | Q3 | — | 46/67 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 137/197 |